RxDoctor Payments Data

Sandhya Dhruvakumar, MD

Clinical Cardiac Electrophysiology · Stamford, CTNPI 1952336091

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,257 of the $3,397 with a category attached, or 66.4%. Abbott accounts for 79.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,321 and has fallen 96.5% since, to $80 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CT, where the typical reported total is $16,507.

$3,397in general payments, 2019–2025

Across 32 payments — averaging $106.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Biotronik Inc.$237
  • Boston Scientific$208
  • Medtronic$163
  • Biosense Webster, Inc.$72
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$20
$5,875in research payments, 2019–2025

Across 13 payments — averaging $451.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$6K

What the payments were for

  • Travel & lodging$2,25766%
  • Food & beverage$1,14034%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,397 in reported general payments places this provider in the 25th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.

See all clinical cardiac electrophysiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$468,746
Medicare patients
1,273
Services billed
6,324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MultaqDronedarone Hcl46$79,028
EliquisApixaban50$60,330
XareltoRivaroxaban23$35,996
Metoprolol Succinate103$1,971
Amiodarone Hcl50$1,071
Diltiazem 24hr Er (Cd)Diltiazem Hcl28$780
SotalolSotalol Hcl13$139

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →